The OriGAMI-4 trial reveals subcutaneous Rybrevant's 45% response rate in metastatic head and neck cancer patients after ...
Malignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic markers is a significant impediment to personalized treatment.
Evidence suggests that oncology patients are satisfied with and sometimes prefer telemedicine compared with in-person visits; however, data are scarce on when telemedicine is appropriate for specific ...
Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ...
Some accompanying symptoms should never be ignored. “Symptoms like hoarseness of voice, swallowing difficulties, ear pain, ...
Regular heavy marijuana use may increase a person’s risk of developing some head and neck cancers, a study published Thursday in JAMA Otolaryngology-Head & Neck Surgery found. The study found that ...
Silicone gel significantly improves head and neck scar quality in a randomised study. Discover the clinical impact and why early use matters. Read more.
This systematic review included searches from PubMed, EMBASE, Web of Science, African Index Medicus, Google Scholar, and African Journals Online. All English publications reporting the proportion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results